Molecular Formula | C₃₂H₃₉N₇O₄ |
Molar Mass | 585.70 |
Storage Condition | -20℃ |
Use | TAK-788 is the next generation of potent and selective small molecule tyrosine kinase inhibitors (TKIs) designed intelligently and investigated clinically to inhibit epidermal growth factor receptor (EGFR) and human EGFR 2 (HER2) exon 20 mutations, has selectivity for wild-type (WT) EGFR. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.707 ml | 8.537 ml | 17.074 ml |
5 mM | 0.341 ml | 1.707 ml | 3.415 ml |
10 mM | 0.171 ml | 0.854 ml | 1.707 ml |
5 mM | 0.034 ml | 0.171 ml | 0.341 ml |